November 2, 2023 Experience Genuine Parts Company $800 million senior notes offering The investment-grade notes are due 2028 and 2033
November 2, 2023 Experience Canadian National Railway $600 million notes offering We advised Canadian National Railway on the offering
November 2, 2023 Experience Morgan Stanley $4 billion senior notes offering We advised Morgan Stanley on its SEC-registered global offering
November 2, 2023 Experience Morgan Stanley Bank $2 billion senior notes offering We advised Morgan Stanley Bank on its 3(a)(2) notes offering
November 1, 2023 Experience Forbion European Acquisition $138 million combination with enGene We advised Forbion European Acquisition on its de-SPAC transaction
October 31, 2023 Experience Air Methods files chapter 11; $155 million DIP and $335 million exit financing We are advising an ad hoc group of first-lien lenders and unsecured noteholders in connection with Air Methods’ chapter 11 restructuring
October 31, 2023 Experience GSK exclusive license agreement for HS-20089 with Hansoh Pharma We advised GSK on the transaction
October 30, 2023 Experience IDEAYA Biosciences $143.8 million equity offering The common stock is listed on the Nasdaq Global Select Market
October 27, 2023 Experience Vinci Partners $100 million placement and strategic partnership with Ares We advised Vinci Partners on the private placement
October 27, 2023 Experience UCT acquisition of HIS Innovations Group We advised UCT on the acquisition